2021 annual financial data
C4 Therapeutics 2021 Operating cash flow margin
C4 Therapeutics 2021 operating cash flow margin with verified reported values.
Direct answer
Operating cash flow margin was -189.94%.
Operating income was -82,134,000 USD and net income was -83,892,000 USD.
Operating cash flow was -86,965,000 USD.
Get free C4 Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 45,785,000 USD
- Operating income
- -82,134,000 USD
- Net income
- -83,892,000 USD
- Operating cash flow
- -86,965,000 USD